Ablative techniques in hepatocellular carcinoma treatment

Abstract

Hepatocellular carcinoma has been known to arise commonly in the setting of chronic liver disease. Due to its association with cirrhosis, patients with hepatocellular carcinoma often present with markedly diminished hepatic functional reserve, making them poor surgical candidates. For such patients, image-guided percutaneous ablative modalities have provided a viable alternate curative therapy. Although treatment allocation is a decision based on a number of factors, patients eligible for percutaneous ablation generally include those with early stage disease, hepatocellular carcinoma with disease limited to the liver and no extra-hepatic metastases. While percutaneous ethanol injection is the seminal technique, newer developments have led to it being replaced by percutaneous radiofrequency ablation as the most commonly employed procedure, due to a better efficacy as well as safety profile. Other ablative modalities including microwave ablation, laser ablation and cryotherapy are not as widely available. Furthermore, data comparing their effectiveness with well-established procedures like radiofrequency ablation is limited.

Keywords

Barcelona Clinic liver Cancer staging / chronic liver disease / hepatocellular carcinoma / Milan Criteria / percutaneous ethanol injection / radiofrequency ablation / surgical resection

References

[1] Llovet JM,Bruix J.Hepatocellular carcinoma.Lancet2003;362:1907-17

[2] Bruix J,Llovet JM,Lencioni R,Christensen E,Colombo M,EASL Panel.Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver..J Hepatol2001;35:421-30

[3] Gobal burden of Disease Liver Cancer Collaboration,Abera S,Alam N,Allen C,Alvis-Guzman N,Artaman A,Barac A,Berhane A,Castillo-Rivas J,Choi JY,Dandona L,Dey S,Phuc H,Zaki MS,Fürst T,Hay SI,Jee SH,Khader Y,Kumar A,Larson H,Lunevicius R,McAlinden C,Mendoza W,Moradi-Lakeh M,Nguyen Q,Ogbo F,Pereira DM,Qorbani M,Roshandel G,Sanabria J,Satpathy M,Sepanlou S,Shore H,Mengistu DT,Tran B,Vlassov V,Vos T,Weiderpass E,Yonemoto N,Yu C,Zhu L,Naghavi M.The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional and national level: results from the global burden of disease study 2015.JAMA Oncol2017;3:1683

[4] Jemal A,Center MM,Ward E.Global cancer statistics.CA Cancer J Clin2011;61:69-90

[5] Bolondi L,Siringo S,Casali A,Piscaglia F,Zanetti M.Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.Gut2001;48:251-9 PMCID:PMC1728189

[6] A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the cancer of the liver Italian program (clip).Hepatology1998;28:751-5

[7] Siegel RL,Jemal A.Cancer statistics, 2016.CA Cancer J Clin2016;66:7-30

[8] Cancer Incidence in Five Continents Volume VIII. Lyon: IARC; 2002.

[9] Di Bisceglie AM.Hepatitis B and hepatocellular carcinoma.Hepatology2009;49:S56-60 PMCID:PMC3047495

[10] Llovet JM,Bruix J,Lencioni R,Sherman M,Lotze M,Gores GJ.Design and endpoints of clinical trials in hepatocellular carcinoma..J Natl Cancer Inst2008;100:698

[11] Mazzaferro V,Sposito C,Langer M,Mariani L.Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience.Liver Transpl2011;17 Suppl 2:S44-57

[12] Beasley RP.Hepatitis B virus. The major etiology of hepatocellular carcinoma..Cancer1988;61:1942-56

[13] Shiina S,Niwa Y,Tanaka T,Hamada E,Mutoh H,Nakata R,Shiratori Y,Sugimoto T,Uta Y,Tagawa K,Kawabe T.Multiple-needle insertion method in percutaneous ethanol injection therapy for liver neoplasms.Gastroenterol Jpn1991;26:47-50

[14] Lopez PM,Llovet JM.Systematic review: evidence-based management of hepatocellular carcinoma - an updated analysis of randomized controlled trials.Aliment Pharmacol Ther2006;23:1535-47

[15] Lencioni R.Loco-regional treatment of hepatocellular carcinoma.Hepatology2010;52:762-73

[16] Livraghi T,Lazzaroni S,Morabito A,Salmi A.Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis.A study on 207 patients. Cancer1992;15:925-9

[17] Kuang M,Xie XY,Xu ZF,Yin XY,Lencioni R.Ethanol ablation of hepatocellular carcinoma up to 5.0 cm by using a multipronged injection needle with high-dose strategy..Radiology2009;253:552-61

[18] Lencioni R,Caramella D,Carrai M,Capria A,Conte PF.Treatment of small hepatocellular carcinoma with percutaneous ethanol injection. Analysis of prognostic factors in 105 Western patients..Cancer1995;76:1737-46

[19] Livraghi T,Marin G,De Sio I,Pompili M,Lazzaroni S.Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection..Radiology1995;197:101-8

[20] Khan KN,Yamasaki K,Inoue O,Yano M.Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection..J Hepatol2000;32:269-278

[21] Livraghi T,Lazzaroni S,Torzilli G.Long term results of single session PEI in patients with large hepatocellular carcinoma..Cancer1998;83:48-57

[22] M1 Ebara,Kita K,Fukuda H,Kondo F.Percutaneous ethanol injection for small hepatocellular carcinoma: therapeutic efficacy based on 20-year observation..J Hepatol2005;43:458-64

[23] McGahan JP,Tesluk H,Schneider P.Hepatic ablation with use of radio-frequency electrocautery in the animal model..J Vasc Interv Radiol1992;3:291

[24] Curley SA.Radiofrequency ablation of malignant liver tumors..Oncologist2001;6:14-23

[25] Yin XY,Lu MD,Xu ZF,Liu GJ,Lau WY.Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors..Cancer2009;115:1914-23

[26] Rossi S,Garbagnati F,Quaretti P,Zangrandi A,Silverman D.Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode..AJR Am J Roentgenol1998;170:1015-22

[27] Livraghi T,Lazzaroni S,Ierace T,Gazelle GS.Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions..Radiology2000;214:761-8

[28] Curley SA,Ellis LM,Vallone P.Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis..Ann Surg2000;232:381-91 PMCID:PMC1421151

[29] Iannitti DA,Mayo-Smith WW.Hepatic radiofrequency ablation..Arch Surg2002;137:422-6

[30] Shiina S,Obi S,Koike Y.Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation..Oncology2002;64-8

[31] Buscarini L,Di Stasi M,Quaretti P.Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results..Eur Radiol2001;11:914-21

[32] Lencioni R,Crocetti L,Pina CD,Bartolozzi C.Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation..Radiology2005;234:961-7

[33] Takahashi S,Chung H,Ishikawa E,Tatsumi C,Minami Y,Haji S.Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy..Oncology2007;72 Suppl 1:98-103

[34] Choi D,Rhim H,Lee WJ,Koh KC,Choi MS.Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large singleinstitution series..Eur Radiol2007;17:684-92

[35] Tateishi R,Teratani T.Percutaneous radiofrequency ablation for hepatocellular carcinoma..An analysis of 1000 cases. Cancer2005;103:1201-9

[36] Lin SM,Lin CC,Chen YC.Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less..Gut2005;54:1151-6 PMCID:PMC1774888

[37] Shiina S,Obi S,Tateishi R,Ishikawa T,Yoshida H,Omata M.A randomized controlled trial of radiofrequency ablation versus ethanol injection for small hepatocellular carcinoma..Gastroenterology2005;129:122-30

[38] Lin SM,Lin CC,Chen YC.Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm..Gastroenterology2004;127:1714-23

[39] Lencioni R,Cioni D,Deibert P,Frings H,Zuber I,Bartolozzi C.Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection..Radiology2003;228:235-40

[40] Brunello F,Carucci P,Ciccone G,Sacchetto P,Rizzetto M.Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled trial..Scand J Gastroenterol2008;43:727-35

[41] Choi D,Kim MJ,Kim SH,Lim JH,Kim YI.Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy..Radiology2004;230:135-41

[42] Head HW,Dalrymple NC,El-Merhi FM,Hubbard LG.Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: frequency of diaphragmatic injury..Radiology2007;243:877-84

[43] Llovet JM,Brú C,Salmeron JM,Ganau S,Pagès M,Solé M,Bruix J.Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma..Hepatology2001;33:1124-9

[44] de Baère T,Kuoch V,Sengel C,Gamal El Din M,Elias D.Adverse events during radiofrequency treatment of 582 hepatic tumors..AJR Am J Roentgenol2003;181:695-700

[45] Kasugai H,Oka H,Seki T.Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients..Oncology2007;72 Suppl 1:72-5

[46] Takaki H,Nakatsuka A,Shiraki K,Takeda K.Frequency of and risk factors for complications after liver radiofrequency ablation under CT fluoroscopic guidance in 1500 sessions: single-center experience..AJR Am J Roentgenol2013;200:658-64

[47] Facciorusso A,Muscatiello N.Local ablative treatments for hepatocellular carcinoma: An updated review..World J Gastrointest Pharmacol Ther2016;7:477-89 PMCID:PMC5095567

[48] Pacella CM,Magnolfi F,Caspani B,Bianchini A,Pacella S,Rossi Z.Laser thermal ablation in the treatment of small hepatocellular carcinoma: results in 74 patients..Radiology2001;221:712-20

[49] Pacella CM,Di Lascio FM,Antico E,Magnolfi F,Pretolani S,Sponza M.Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis..J Clin Oncol2009;27:2615-21

[50] Pacella CM,Francica G,De Nuntis S,Crescenzi A,Forlini G,Osborn J.Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis..J Vasc Interv Radiol2005;16:1447-57

[51] Arienti V,Pacella CM,Caspani B,Megna AS,Sponza M,Di Lascio FM.Complications of laser ablation for hepatocellular carcinoma: a multicenter study..Radiology2008;246:947-55

[52] Majumdar A,Thorburn D,Tsochatzis E.Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis..Cochrane Database Syst Rev2017;3:CD011650

[53] Liang P,Yu X,Wang Y,Xiao Q.Prognostic factors for survival in patients with hepatocellular carcinoma after percutaneous microwave ablation..Radiology2005;235:299-307

[54] Lu MD,Xie XY,Chen JW,Xu ZF,Zheng YL.Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study..J Gastroenterol2005;40:1054-60

[55] Dong B,Yu X,Yu D,Zhang J.Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients..AJR Am J Roentgenol2003;180:1547-55

[56] Yamashiki N,Bejarano PA,Montalvo B,Goodman ZD,Schiff ER.Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers..Am J Gastroenterol2003;98:2052-9

[57] Martin RC,McMasters KM.Safety and efficacy of microwave ablation of hepatic tumors: a prospective review of a 5-year experience..Ann Surg Oncol2010;17:171-8

[58] Ma S,Li J,Qi X,Ming Y,Wang Z,Cui D,Zhai B.Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors..J Cancer Res Clin Oncol2017;143:131

[59] Choti MA.Surgical management of hepatocellular carcinoma: resection and ablation..J Vasc Interv Radiol2002;13:S197-S203

[60] Huang J,Cheng Z,Du L,Xu Y.A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria..Ann Surg2010;252:903-12

[61] Pompili M,Covino M,Caturelli E,Villani MR,Gasbarrini G.Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy..Cancer2001;92:126-35

[62] Giorgio A,De Stefano G,Farella N,Esposito V,Giorgio V.Percutaneous radiofrequency ablation of hepatocellular carcinoma compared to percutaneous ethanol injection in treatment of cirrhotic patients: an Italian randomized controlled trial..Anticancer Res2011;31:2291-5